Injectable Nanocomposite Immune Hydrogel Dressings: Prevention of Tumor Recurrence and Anti‐Infection after Melanoma Resection
Small · 2024
DOI: 10.1002/smll.202309476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Wenxiang Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Hunan University, Changsha, 410082, China. Hauptthemen laut MEDLINE: Nanocomposites. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: The National Key Research and Development Program of China, Natural Science Foundation of Hunan Province, Natural Science Foundation of Changsha City.
Abstract (Originalsprache)
Complex wound repair due to tumor recurrence and infection following tumor resection presents significant clinical challenges. In this study, a bifunctional nanocomposite immune hydrogel dressing, SerMA‐LJC, is developed to address the issues associated with repairing infected damaged tissues and preventing tumor recurrence. Specifically, the immune dressing is composed of methacrylic anhydride‐modified sericin (SerMA) and self‐assembled nanoparticles (LJC) containing lonidamine (Lon), JQ1, and chlorine e6 (Ce6). In vitro and in vivo experiments demonstrate that the nanocomposite hydrogel dressing can trigger immunogenic cell death (ICD) and has a potent anti‐tumor effect. Moreover, this dressing can mitigate the acidic microenvironment of tumor cells and suppress the overexpression of PD‐L1 on the tumor cell surface, thereby altering the immunosuppressive tumor microenvironment and augmenting the anti‐tumor immune response. Further, the RNA sequencing analysis revealed that the hydrogel dressing significantly impacts pathways associated with positive regulation of immune response, apoptotic process, and other relevant pathways, thus triggering a potent anti‐tumor immune response. More importantly, the dressing generates a substantial amount of reactive oxygen species (ROS), which can effectively kill Staphylococcus aureus and promote infectious wound healing. In conclusion, this dual‐function nanocomposite immune hydrogel dressing exhibits promise in preventing tumor recurrence and promoting infectious wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Hunan University, Changsha, 410082, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
- College of Biology, Hunan University, Changsha, 410082, China.
- Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital of Southern Medical University (Dongguan people's hospital), Dongguan, 523058, China.
- Jingzhou Central Hospital, The Second Clinical Medical College of Yangtze University, Jingzhou, 434020, China.
ORCID-Profile: Hairong Liu
Förderung
- The National Key Research and Development Program of China
- Natural Science Foundation of Hunan Province
- Natural Science Foundation of Changsha City
Zitieren
APA
Zhu, W., Zhou, Z., Yang, M., Chen, X., Zhu, S., Yu, M., Yu, Z., Wu, W., & Liu, H. (2024). Injectable Nanocomposite Immune Hydrogel Dressings: Prevention of Tumor Recurrence and Anti‐Infection after Melanoma Resection. Small. https://doi.org/10.1002/smll.202309476
Vancouver
Zhu W, Zhou Z, Yang M, Chen X, Zhu S, Yu M, et al. Injectable Nanocomposite Immune Hydrogel Dressings: Prevention of Tumor Recurrence and Anti‐Infection after Melanoma Resection. Small. 2024. doi:10.1002/smll.202309476
BibTeX
@article{Zhu2024,
author = {Zhu, Wenxiang and Zhou, Zheng and Yang, Mengni and Chen, Xin and Zhu, Shuai and Yu, Mengyi and Yu, Zhiqiang and Wu, Wenze and Liu, Hairong},
title = {Injectable Nanocomposite Immune Hydrogel Dressings: Prevention of Tumor Recurrence and Anti‐Infection after Melanoma Resection},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202309476}
}
EUVIMED